Adrenergic and dopaminergic G-protein-coupled receptor (AR/DR GPCR)

Adrenergic and dopaminergic G-protein-coupled receptors (GPCRs) are a broad class of membrane-bound receptors that respond to the endogenous catecholamines epinephrine, norepinephrine, and dopamine. These receptors are critical components of the autonomic nervous system and the central nervous system, where they regulate essential processes such as heart rate, vascular resistance, airway tone, and complex behaviors like reward and motor control (Source: StatPearls, "Physiology, Adrenergic Receptor"). Adrenergic receptors are categorized into alpha (α1, α2) and beta (β1, β2, β3) subtypes, while dopamine receptors are divided into D1-like (D1, D5) and D2-like (D2, D3, D4) families (Source: IUPHAR/BPS Guide to Pharmacology). Due to their pervasive role in physiology, they are primary targets for a wide range of medications, including antihypertensives, bronchodilators, and antipsychotics (Source: PubMed, PMID: 29073317). However, the high degree of structural homology between these receptors often leads to cross-reactivity, where a drug intended for one receptor type may interact with others, resulting in side effects such as tachycardia or movement disorders (Source: NIH, PMCID: PMC2856180). Consequently, drug development in this space focuses heavily on achieving subtype selectivity to maximize therapeutic index. These receptors function primarily through the activation of heterotrimeric G proteins, which modulate intracellular second messengers like cyclic AMP and phospholipase C (Source: UniProt). Dysregulation of these signaling pathways is implicated in numerous conditions, ranging from congestive heart failure to schizophrenia and Parkinson's disease.

Other names

Catecholamine receptorAdrenoceptor and dopamine receptorAdrenergic and dopaminergic receptor

Drugs targeting these receptors function as agonists, partial agonists, or antagonists that modulate G-protein-coupled signaling cascades, specifically involving Gs (stimulatory), Gi (inhibitory), or Gq (phospholipase C activation) proteins to regulate intracellular second messenger concentrations (Source: IUPHAR/BPS Guide to Pharmacology).